GMED's research was recently posted in a medical journal on October 20th in their efforts to combat the bird flu. Yesterday's press was filled with fears of it spreading human to human.
In addition, something that I think will be very interesting is the trickle down effect of Michael Moore's new documentary on the pharmaceutical companies. Moore aims to expose the unethical behaviors of the companies and their reluctance to create a cure for reasons of losing $$$. This very well could create a much larger acceptance of GENOMED's treatments and create more political pressure to look at alternatives to the rising costs of healthcare. The almighty dollar speaks volumes and by Moskowitz claiming he has treatments that are much cheaper than the pharmaceutical drugs we are paying so much for, it's easy to understand why his practices haven't been promoted within the medical field.
According to an email I received from Dr. Moskowitz, he had contacted Moore's people and informed them of the problems he was having. Moore's people were interested in what he had to say. Whether the company gets direct advertisement from the documentary is not known.
Market Data 
Markets 
AI
